Fischer Medical Ventures

845.00
+24.60
(3.00%)
ann
There are 2 new updates from the company12 hours ago
Viewcross
right
Market Cap
5,391.25 Cr
EPS
1.65
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals
52 Week High
907.00
52 Week Low
454.35
PB Ratio
15.29
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
847.80
#1 21,598.24
48.91
#1 15,707.00
-7.64
449
-110.82
51.00
1,140.80
14,401.21
16.17
8,798.90
-22.71
457
#1 318.35
55.81
504.85
7,418.30
14.13
8,398.90
-20.68
485
68.04
49.20
434.90
6,876.19
-
4,003.40
-20.27
-158
45.41
48.36
599.75
5,742.89
#1 9.80
3,498.80
-23.68
#1 794
68.74
40.93
583.50
4,285.53
-
3,896.70
-14.52
-237
90.27
54.48
2,930.70
2,923.39
37.12
385.20
0.60
53
244.55
40.11
85.09
2,806.79
23.76
1,099.90
9.90
146
0.70
38.73
242.12
2,479.02
-
2,102.50
-2.77
-39
-82.61
51.59
845.00
#6 5,391.25
-
#10 21.50
#1 10,650.00
#7 2
#6 62.50
62.48
Growth Rate
Revenue Growth
10,650.00 %
Net Income Growth
5,135.34 %
Cash Flow Change
-165.49 %
ROE
-83.45 %
ROCE
-46.88 %
EBITDA Margin (Avg.)
29.78 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
0
21
11
40
12
Expenses
0
0
1
18
10
39
11
EBITDA
0
0
-1
3
1
1
1
Operating Profit %
0 %
0 %
-347 %
12 %
-3 %
1 %
3 %
Depreciation
0
0
0
0
0
0
1
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
-1
3
0
0
0
Tax
0
0
0
0
0
-0
0
Net Profit
0
0
-1
3
-0
0
-0
EPS in ₹
0.00
0.00
0.00
0.48
-0.02
0.05
-0.05

Balance Sheet

Balance Sheet
2023
2024
Total Assets
0
86
Fixed Assets
0
15
Current Assets
0
70
Capital Work in Progress
0
0
Investments
0
1
Other Assets
0
70
Total Liabilities
0
86
Current Liabilities
0
4
Non Current Liabilities
1
1
Total Equity
-0
81
Reserve & Surplus
-0
27
Share Capital
0
54

Cash Flow

Cash Flow
2024
Net Cash Flow
1
Investing Activities
-29
Operating Activities
-8
Financing Activities
37

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Jan 2024
Mar 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Feb 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
74.91 %
74.91 %
74.91 %
74.91 %
62.81 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
5.07 %
5.07 %
5.07 %
5.07 %
5.07 %
5.06 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.68 %
1.68 %
1.68 %
1.68 %
1.68 %
1.41 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
96.72 %
96.72 %
96.61 %
94.42 %
94.38 %
94.43 %
94.43 %
94.23 %
94.20 %
99.60 %
97.60 %
97.59 %
29.75 %
29.37 %
16.47 %
16.48 %
16.39 %
16.37 %
25.30 %
Others
3.28 %
3.28 %
3.39 %
5.58 %
5.62 %
5.57 %
5.57 %
5.77 %
5.80 %
0.40 %
2.40 %
2.41 %
70.25 %
63.88 %
1.87 %
1.86 %
1.94 %
1.96 %
5.41 %
No of Share Holders
9,046
9,043
9,085
9,109
9,093
9,121
9,121
9,064
9,060
9,085
9,104
9,038
9,065
8,976
8,975
9,285
9,502
9,688
9,865

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Resignation of Director12 hours ago
Reconstitution Of Committees18 hours ago
Announcement under Regulation 30 (LODR)-Resignation of Director1 day ago
Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th March 20251 day ago
Update By Material Subsidiary2 days ago
Board Meeting Intimation for Change In Independent Director And Other Related And General Corporate Purpose3 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 07, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 04, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMar 04, 2025
Integrated Filing (Financial)Mar 03, 2025
Announcement under Regulation 30 (LODR)-AllotmentMar 03, 2025
Integrated Filing (Financial)Mar 03, 2025
Announcement Relating To Proposed Investment Of Funds In Wholly Owned SubsidiaryFeb 26, 2025
Announcement Relating To Proposed Investment Of Funds In Wholly Owned SubsidiaryFeb 26, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 24, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 21, 2025
Update On Receipt Of Disclosure Under Regulation 29(2) Of SEBI (SAST) 2015Feb 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 18, 2025
Board Meeting Outcome for Allotment Of Equity Shares And WarrantsFeb 18, 2025
Announcement Under Regulation 30 - Incorporation Of Subsidiary CompanyFeb 15, 2025
Board Meeting Outcome for RESULTS - FINANCIAL RESULTS - 31.12.2024Feb 14, 2025
Results - Financial Results For 31/12/2024Feb 14, 2025
Update From Material SubsidiaryFeb 13, 2025
Announcement Under Regulation 30 - Update On Re- Constitution Of Audit CommitteeFeb 12, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31.12.2024Feb 07, 2025
Intimation Of Supply Of 10 Nos. Of 1.5T Whole Body MRI Machines To Atrium DiagnosticsFeb 05, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 02, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 02, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesJan 31, 2025
Proceedings Of Extra Ordinary General Meeting Dated 31.01.2025Jan 31, 2025
Intimation Of Development Of Advanced AI Powered Healthcare Solutions By Wholly Owned Subsidiary Of The CompanyJan 27, 2025
Intimation Of Launch Of Sikkim MRI Public - Private Partnership (PPP) ProjectJan 20, 2025
Intimation Of License To Manufacture MRI By CDSCO To The Material Subsidiary Of The CompanyJan 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 10, 2025
Shareholders Meeting - EGM On 31/01/2025Jan 09, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesJan 03, 2025
Board Meeting Outcome for Outcome Of Board Meeting Is Enclosed HerewithJan 03, 2025
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationDec 28, 2024
Announcement Under Regulation 30- Update On Upcoming Board MeetingDec 28, 2024
Board Meeting Intimation for To Consider Approve Business Items Relating To Preferential Issue And Other Business ItemDec 28, 2024
General UpdateDec 16, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressNov 30, 2024
Update Of Incorporation Of Subsidiary CompanyNov 14, 2024
RESULTS 30/09/2024Nov 14, 2024
Board Meeting Outcome for OUTCOME OF BOARD MEETINGNov 14, 2024
Board Meeting Scheduled On 13/11/2024 To Consider And Approve Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2024Nov 05, 2024

Technical Indicators

RSI(14)
Neutral
62.48
ATR(14)
Less Volatile
55.49
STOCH(9,6)
Neutral
60.53
STOCH RSI(14)
Neutral
67.26
MACD(12,26)
Bullish
0.35
ADX(14)
Weak Trend
24.79
UO(9)
Bearish
59.29
ROC(12)
Uptrend And Accelerating
5.17
WillR(14)
Neutral
-33.77